master's thesis
Liječenje hiperlipidemija PCSK9 inhibitorima

Santini, Mihovil
University of Zagreb
School of Medicine
Department of Internal Medicine

Cite this document

Santini, M. (2022). Liječenje hiperlipidemija PCSK9 inhibitorima (Master's thesis). Zagreb: University of Zagreb, School of Medicine. Retrieved from https://urn.nsk.hr/urn:nbn:hr:105:958157

Santini, Mihovil. "Liječenje hiperlipidemija PCSK9 inhibitorima." Master's thesis, University of Zagreb, School of Medicine, 2022. https://urn.nsk.hr/urn:nbn:hr:105:958157

Santini, Mihovil. "Liječenje hiperlipidemija PCSK9 inhibitorima." Master's thesis, University of Zagreb, School of Medicine, 2022. https://urn.nsk.hr/urn:nbn:hr:105:958157

Santini, M. (2022). 'Liječenje hiperlipidemija PCSK9 inhibitorima', Master's thesis, University of Zagreb, School of Medicine, accessed 16 June 2024, https://urn.nsk.hr/urn:nbn:hr:105:958157

Santini M. Liječenje hiperlipidemija PCSK9 inhibitorima [Master's thesis]. Zagreb: University of Zagreb, School of Medicine; 2022 [cited 2024 June 16] Available at: https://urn.nsk.hr/urn:nbn:hr:105:958157

M. Santini, "Liječenje hiperlipidemija PCSK9 inhibitorima", Master's thesis, University of Zagreb, School of Medicine, Zagreb, 2022. Available at: https://urn.nsk.hr/urn:nbn:hr:105:958157

Please login to the repository to save this object to your list.